AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 121 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $220,000 | +101.8% | 23,400 | +63.6% | 0.00% | 0.0% |
| Q2 2020 | $109,000 | +43.4% | 14,300 | +16.0% | 0.00% | – |
| Q1 2020 | $76,000 | -57.8% | 12,327 | -31.5% | 0.00% | -100.0% |
| Q2 2019 | $180,000 | -13.5% | 18,000 | +31.4% | 0.00% | +100.0% |
| Q4 2018 | $208,000 | -64.9% | 13,700 | -53.7% | 0.00% | -66.7% |
| Q3 2018 | $592,000 | +11.1% | 29,600 | +2.4% | 0.00% | +50.0% |
| Q3 2017 | $533,000 | +136.9% | 28,919 | +139.0% | 0.00% | +100.0% |
| Q2 2017 | $225,000 | -42.3% | 12,100 | +8.0% | 0.00% | -66.7% |
| Q4 2016 | $390,000 | +1158.1% | 11,200 | +775.0% | 0.00% | – |
| Q3 2016 | $31,000 | -29.5% | 1,280 | -32.6% | 0.00% | – |
| Q1 2016 | $44,000 | +528.6% | 1,900 | +1800.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |